We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
Moderna released a personalized mRNA vaccine against pancreatic cancer: remission in 78% of patients over 18 months. FDA accelerated approval. Analysis of efficacy and risks.
